A controlled prospective randomized study was designed to analyze the effect of extracorporeal shock wave therapy on calcifying tendinopathy of the shoulder focused on the calcified area or the origin of the supraspinatus tendon. Fifty patients were included in the study and were treated with a Storz Minilith Sl-1 shock wave generator. The first group of patients received 4000 impulses (positive energy flux density, 0.78 mJ/mm 2 ) in two treatment sessions after receiving local anesthesia at the origin of the supraspinatus tendon. Patients in the second group received extracorporeal shock wave therapy at the calcified area. Followups were done 12 weeks and 1 year after treatment by an independent observer. An increase of function and a reduction of pain occurred in both groups. Statistical analyses showed a significant superiority of extracorporeal shock wave application at the calcified area in the primary end point (Constant and Murley score). Therefore, exact fluoroscopic focusing of extracorporeal shock wave therapy at the calcific deposit for treatment of calcifying tendinopathy of the supraspinatus muscle is recommended. Based on these results, extracorporeal shock wave application should be focused fluoroscopically with appropriate shock wave generators.
A controlled prospective randomized study was designed to analyze the effect of extracorporeal shock wave therapy on calcifying tendinopathy of the shoulder focused on the calcified area or the origin of the supraspinatus tendon. Fifty patients were included in the study and were treated with a Storz Minilith Sl-1 shock wave generator. The first group of patients received 4000 impulses (positive energy flux density, 0.78 mJ/mm 2 ) in two treatment sessions after receiving local anesthesia at the origin of the supraspinatus tendon. Patients in the second group received extracorporeal shock wave therapy at the calcified area. Followups were done 12 weeks and 1 year after treatment by an independent observer. An increase of function and a reduction of pain occurred in both groups. Statistical analyses showed a significant superiority of extracorporeal shock wave application at the calcified area in the primary end point (Constant and Murley score). Therefore, exact fluoroscopic focusing of extracorporeal shock wave therapy at the calcific deposit for treatment of calcifying tendinopathy of the supraspinatus muscle is recommended. Based on these results, extracorporeal shock wave application should be focused fluoroscopically with appropriate shock wave generators.
Calcifying tendinopathy of the supraspinatus muscle is a common problem in orthopaedic practice. 14 The incidence of calcifications in the muscles of the rotator cuff varies from 2.5% to 20% in patients with asymptomatic shoulders and as much as 54% in patients with shoulder disorders. 2, 10 The usual site is the tendon of the supraspinatus. 2 Calcifying tendinopathy may
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be attributable to chronic degenerative changes in tendinous tissue with formation of metaplastic chondroid tissue. 25 Patients with calcifying tendinopathy usually are treated with physiotherapy, analgesics, and subacromial injection with steroids and local anesthetics. 24 Although the disease may be self-limiting, 10 chronic pain with time is possible and approximately 10% of patients may require surgery. 11 Extracorporeal shock wave therapy for treatment of insertion tendinopathies first was used in Germany and Austria. 8, 15 In the past year, extracorporeal shock wave therapy for therapy of heel spurs received Food and Drug Administration approval in the United States. 16 All major lithotripter manufacturers currently are planning or doing multicenter studies to obtain Food and Drug Administration approval for different indications. Extracorporeal shock wave therapy as a new method to treat calcifying tendinopathy first was described as a case report of six patients in 1992. 8 Clinical success is reported in 60% to 80% of patients from uncontrolled prospective trials. 13, 19, 21, 22 Loew et al 17 showed the efficacy of high-energy extracorporeal shock wave therapy (2 ϫ 2000 pulses; 0.3 mJ/mm 2 ) in a controlled prospective study, and had good clinical results in 58% of patients. Radiologic disintegration rates of the calcific deposit after extracorporeal shock wave therapy vary from 47% to 77%. 17, 18 In clinical practice, shock waves usually are aimed at the painful area at the insertion of the tendon, the biofeedback method, and not focused with radiographic or ultrasound guidance. This procedure is recommended by some authors 5, 7 and by the producers of shock wave generators. 9 Although good success rates of extracorporeal shock wave therapy have been reported if the shock waves are focused using fluoroscopy, 18, 21 the majority of patients are treated without fluoroscopic focusing.
The aim of the current study was to determine the influence of exact fluoroscopic focusing of extracorporeal shock wave therapy at the calcific deposit compared with aiming the shock waves at the insertion of the muscle on the clinical outcome in calcifying tendinopathy of the supraspinatus muscle.
MATERIAL AND METHODS

Protocol
This study was a prospective, blinded trial with a randomized two-sample parallel-group design. The primary end point (Constant and Murley score 6 during followup) was assessed by blinded independent observers. The sample size was 25 patients in each group. Inclusion and exclusion criteria are shown in Table 1 . A radiograph of the affected shoulder (not older than 2 weeks) confirmed the diagnosis of calcifying tendinopathy with a deposit Stage I or II according to Gärtner 10 with at least 0.5 cm diameter. All patients in the first group were treated with extracorporeal shock waves in two ses- Fig 1) . Technical specifications of the device and the focusing procedure have been described previously. 12 Subacromial local anesthesia was given using 15 mL mepivacaine 1%. Two thousand impulses of a positive energy flux density of 0.35 mJ/mm 2 measured with a membrane hydrophone (equivalent to 0.78 mJ/mm 2 measured with a fiberoptic hydrophone; Table 2 ) at 120 impulses per minute were applied using fluoroscopic local-ization at the origin of the supraspinatus tendon ( Fig 2A) and at intervals during treatment. Patients in the second group were treated with extracorporeal shock wave therapy combined with local anesthesia under the same conditions except the shock waves were aimed exactly at the calcific deposit ( Fig 2B) . The clinician checked the inclusion and exclusion criteria (Table 1 ) and obtained signed informed consent from all patients before the randomization. Before consenting, the patients were informed orally regarding the study and received an information sheet. All patients were evaluated using a questionnaire before randomization including the Constant and Murley score, subjective pain rate on a visual numeric rating scale from 0 (no pain) to 11 (maximum pain) for pain during activity and pain during rest. Rupture of the rotator cuff was excluded by ultrasound or magnetic resonance imaging (MRI). Twelve weeks and 1 year after treatment, the patient was reevaluated by an independent observer with the same questionnaire. The primary outcome measure of the study was the success rate 12 weeks after the last treatment, with success being defined as 80% of the normal value in the age-corrected Constant and Murley score. This outcome is considered clinically relevant. The target sample size was projected by an estimated duration of the treatment of 1 year. Comparative analyses were done on an intention-to-treat basis.
No prospective rules were defined for stopping the study and no interim analysis was planned. The study protocol was approved by the ethics committee at the authors' institution.
Assignment
After being entered into the study, the patient was randomized using random permutated blocks. The treatment group assigned to the patient was written on the treatment protocol that was separated from the evaluation protocol used by the independent observer. The observer was not involved in the treatment of the patient nor knew to which group the patient was assigned.
Masking
The set-up in both groups was identical. The monitor of the mobile fluoroscopy unit was positioned outside the sight of the patient. Only the physician doing the intervention knew the treatment group.
Statistical Analysis
The SPSS 10.0 software program (Statistical Packet for the Social Sciences, SPSS Inc, Chicago, IL) was used for analysis of the study results. For statistical analysis of the differences between both groups, Student's t test for nonpaired samples was used (␣ Յ 0.05). Before using the t test, the Kolmogorov-Smirnov test for normal distribution of the data and equal variances was done. Ninety-five percent confidence intervals were calculated for the differences between both groups with SPSS 10.0.
RESULTS
Participant Flow and Followup
Between September 1998 and December 1999, 50 patients were included in the study. Thirty-five patients were women and 15 were men. In 24 patients, the right shoulder was affected, and in the other 26 patients, the left shoulder was affected. The mean age of the patients at the time of randomization was 50 years with a minimum of 29 years and a maximum of 68 years. The mean Constant and Murley score before treatment was 48.6 with a minimum of 21 and a maximum of 67. The pain during activity ranged from 5 to 11 with an average of 8.5, and the pain during rest ranged from 1 to 11 with an average of 7. A flow diagram showing the progress of patients throughout the trial is shown in Figure 3 Table 3 shows the numerical results of the study as a comparison between groups. Figure  4 shows a plot of the 95% confidence interval of the Constant and Murley score results for both groups at the initial examination and 12 weeks and 1 year after intervention. The rate of complete resorption of the calcific deposit in each group 1 year after extracorporeal shock wave therapy is shown in Table 4 for 46 patients. A chi square test at a level of ␣ Ͻ 0.05 showed no significant difference in the resorption rate.
DISCUSSION
Extracorporeal shock wave therapy has been used in Germany and Austria for treatment of calcifying and noncalcifying tendinopathy of the shoulder since 1992. The number of applications in the orthopaedic area, with an estimated 60,000 to 100,000 patients annually in Germany, has exceeded the number of applications of lithotripsy in urology. 23 Until now, a pain-triggered or laser-guided application to the insertion of a tendon without ultrasound or fluoroscopic imaging of the target area has been recommended for all indications including calcifying tendinopathy. 4, 5, 8 In clinical practice, the treatment of calcifying tendinopathy is done analogous to the treatment of other insertion tendinopathies such as tennis elbow using the biofeedback method.
Contrary to other indications, 15, 23 Loew et al 17 showed the efficacy of high-energy extracorporeal shock wave therapy in a controlled prospective study for treatment of calcifying tendinopathy of the shoulder. Based on this study, the current authors examined the effect of different focusing sites of the shock waves and therefore used similar energy flux densities and the same treatment protocol for shock wave application.
Significantly better 1-year results (t test, ␣ Ͻ 0.05) were seen in all observed parameters if extracorporeal shock wave therapy was aimed exactly at the calcific deposit. After 12 weeks, all parameters except pain at rest showed a significant improvement compared with the other group (extracorporeal shock wave therapy focused on the insertion of the supraspinatus tendon).
The current clinical results of the patients in the Calcific Deposit Group are better than results reported by Loew et al. 17 The reason for this may be the more exact localization of the Fig 3. This flow diagram shows the progress of patients throughout the trial: One patient from each group did not return for the 12-week followup because of another disorder. Both patients were evaluated at the 1-year followup. One patient in the Tuberculum Majus Group withdrew his consent after randomization. No other deviations from the study protocol occurred. calcific deposit from two angles before beginning the treatment and continuous observation during extracorporeal shock wave therapy every 200 to 300 pulses. The authors did not determine whether the in-line radiographic localization through the cylindrical source of the shock wave generator is more effective than off-line radiographic localization used by others. Based on the current results, it seems important to keep the focal spot constantly at the calcific deposit during the entire treatment. In some cases, the patient's arm has to be rotated slightly or flexed, enabling the clinician to aim exactly at the deposit and not to affect other superimposed structures.
The mechanisms of the therapeutic effect of extracorporeal shock wave therapy for treatment of calcifying tendinopathy are uncertain. Although some authors favor the theory of a direct mechanical disintegrating effect on the deposit, 17 others prefer long-lasting hyperstimulation analgesia. 8, 22 The current results do not support the disintegrating theory because there was no significant difference found in the resorption rate between both groups although the clinical results were statistically different. For patients in the group in which the extracorporeal shock waves were focused on the tuberculum majus, there was improvement in the Constant and Murley score and pain, which is comparable with the natural history of the disease. 10 Although no severe side effects were found, it might be disadvantageous to hit other struc-tures such as cartilage or bone with an unguided application of high-energy shock waves. The frequency with which hematomas occur seems to be dependent on the energy used, as seen when using a Dornier Compact lithotriptor. 3 By using MRI, no changes in muscular tissue in patients after extracorporeal shock were therapy of the shoulder were detected applying an energy flux density of 0.28 mJ/mm 2 , but in one patient, a transient edema of the bone could be seen. 18 However, Maier et al 20 found changes in the MRI signal intensity of the tendinous insertion after extracorporeal shock wave therapy at the shoulder. These findings underline the importance of exact focusing.
The study results suggest that extracorporeal shock wave therapy with 2 ϫ 2000 impulses of a positive energy flux density of 0.78 mJ/mm 2 (ϭ 0.35 mJ/mm 2 measured with a membrane hydrophone) was highly effective for treatment of calcifying tendinopathy of the supraspinatus muscle when it was focused exactly using fluoroscopic control at the calcific deposit. It should not be used without exact focusing as a biofeedback procedure to the insertion of the muscle. Based on the results of the current study, shock wave generators should be built with the ability to focus the shock waves with fluoroscopic imaging. A chi 2 test (␣ Ͻ 0.05) showed no significant difference between both groups.
CD group ϭ focus of shock waves at calcific deposit TM group ϭ focus of shock waves at tuberculum majus
